Insight for what’s next
The Institute@Precision was created to bring together the people driving discovery, development, and delivery, and to turn their collective experience into shared insight. It's a collaborative space for learning, connecting, and accelerating progress across the entire precision development and commercialization pathway.
Perspectives that span R&D and commercialization
Access perspectives that are deeply rooted in real world experience, across the entire drug lifecycle, from early research through development, access and commercialization.
and PharmDs
One hot topic every quarter. Multiple expert perspectives.
Each Institute@Precision series puts a timely issue under the microscope. Through the eyes of experts from across the healthcare continuum, we explore the challenges and opportunities that determine how innovations reach patients.
APAC’s impact is no longer regional. It is redefining how innovative therapies
move from development to global markets. What does it take to turn APAC’s
emerging opportunities into strategic advantage?
Radiopharmaceuticals are attracting unprecedented attention, investment and optimism. Our quarterly series cuts through the complexities, bringing together expert points of view on the research, regulatory, operational and commercial realities driving the narrative.
ADCs have transformed oncology, but the road ahead is far from straightforward. Explore the perspectives, lessons and strategic considerations influencing the next era of ADC development.
Insights in your inbox
Institute@Precision works as an ever-evolving dialogue. Go deep into emerging topics, surface your own perspectives and help influence the crucial conversations happening across biopharma.
See what the experts see.
Moving from molecule to market with Precision
Institute@Precision draws on expertise from across Precision Medicine Group. Together our organizations span the spectrum from molecule to market, providing actionable answers to the most pressing questions in healthcare innovation, from multiple angles.
Precision Medicine Group is a global team of 3,500 experts operating across two groups: Precision for Medicine and Precision AQ, supporting life science organizations from the lab to trials to launch and through product maturity.
Precision for Medicine helps sponsors navigate the complex development pathway through scientific expertise, clinical excellence and data-driven insights.
Precision AQ helps innovators translate evidence into action, combining strategy, insight and communications expertise to enable broader access to life-changing medicines.



